BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19362737)

  • 1. Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk.
    Hosgood HD; Baris D; Zhang Y; Berndt SI; Menashe I; Morton LM; Lee KM; Yeager M; Zahm SH; Chanock S; Zheng T; Lan Q
    Leuk Res; 2009 Dec; 33(12):1609-14. PubMed ID: 19362737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.
    Lee KM; Baris D; Zhang Y; Hosgood HD; Menashe I; Yeager M; Zahm SH; Wang SS; Purdue MP; Chanock S; Zheng T; Rothman N; Lan Q
    Am J Hematol; 2010 Aug; 85(8):560-3. PubMed ID: 20568250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase polymorphisms and genetic susceptibility to multiple myeloma.
    Hosgood HD; Baris D; Zhang Y; Zhu Y; Zheng T; Yeager M; Welch R; Zahm S; Chanock S; Rothman N; Lan Q
    Hematol Oncol; 2008 Sep; 26(3):148-51. PubMed ID: 18381704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in innate immunity genes and risk of multiple myeloma.
    Purdue MP; Lan Q; Menashe I; Zheng T; Zhang Y; Yeager M; Hosgood HD; Zahm SH; Chanock SJ; Rothman N; Baris D
    Hematol Oncol; 2011 Mar; 29(1):42-6. PubMed ID: 20658475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.
    Martino A; Campa D; Jurczyszyn A; Martínez-López J; Moreno MJ; Varkonyi J; Dumontet C; García-Sanz R; Gemignani F; Jamroziak K; Stępieł A; Jacobsen SE; Andersen V; Jurado M; Landi S; Rossi AM; Lesueur F; Marques H; Dudziński M; Wątek M; Moreno V; Orciuolo E; Petrini M; Reis RM; Ríos R; Sainz J; Vogel U; Buda G; Vangsted AJ; Canzian F
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):670-4. PubMed ID: 24521996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between CASP7 and CASP14 genetic polymorphisms and the risk of childhood leukemia.
    Park C; Han S; Lee KM; Choi JY; Song N; Jeon S; Park SK; Ahn HS; Shin HY; Kang HJ; Koo HH; Seo JJ; Choi JE; Kang D
    Hum Immunol; 2012 Jul; 73(7):736-9. PubMed ID: 22548721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.
    Birmann BM; Tamimi RM; Giovannucci E; Rosner B; Hunter DJ; Kraft P; Mitsiades C; Anderson KC; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):282-8. PubMed ID: 19124510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.
    Rajaraman P; Wang SS; Rothman N; Brown MM; Black PM; Fine HA; Loeffler JS; Selker RG; Shapiro WR; Chanock SJ; Inskip PD
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1655-61. PubMed ID: 17684142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.
    Hosgood HD; Menashe I; Shen M; Yeager M; Yuenger J; Rajaraman P; He X; Chatterjee N; Caporaso NE; Zhu Y; Chanock SJ; Zheng T; Lan Q
    Carcinogenesis; 2008 Oct; 29(10):1938-43. PubMed ID: 18676680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Large-scale genetic association study of esophageal adenocarcinoma risk.
    Liu CY; Wu MC; Chen F; Ter-Minassian M; Asomaning K; Zhai R; Wang Z; Su L; Heist RS; Kulke MH; Lin X; Liu G; Christiani DC
    Carcinogenesis; 2010 Jul; 31(7):1259-63. PubMed ID: 20453000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
    Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
    Cozen W; Gebregziabher M; Conti DV; Van Den Berg DJ; Coetzee GA; Wang SS; Rothman N; Bernstein L; Hartge P; Morhbacher A; Coetzee SG; Salam MT; Wang W; Zadnick J; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2285-91. PubMed ID: 17119059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation and human longevity.
    Soerensen M
    Dan Med J; 2012 May; 59(5):B4454. PubMed ID: 22549493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
    Mesic A; Rogar M; Hudler P; Bilalovic N; Eminovic I; Komel R
    BMC Cancer; 2019 Sep; 19(1):919. PubMed ID: 31521144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.
    Nielsen KR; Rodrigo-Domingo M; Steffensen R; Baech J; Bergkvist KS; Oosterhof L; Schmitz A; Bødker JS; Johansen P; Vogel U; Vangsted A; Dybkær K; Bøgsted M; Johnsen HE
    Leuk Lymphoma; 2017 Nov; 58(11):2695-2704. PubMed ID: 28393658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.